PGT-A Testing in India: Cost, Accuracy, and Who Actually Needs It

Preimplantation genetic testing for aneuploidy, commonly called PGT-A, is an advanced laboratory test used during IVF to examine embryos for abnormalities in chromosome number before embryo transfer.

For couples researching embryo genetic testing in India, one of the biggest questions is whether PGT-A is actually necessary. Another is the PGT-A testing cost in India, which can add a significant amount to an already expensive IVF cycle.

PGT-A can help identify embryos that appear chromosomally euploid, meaning they have the expected chromosome number. However, it is important to understand that PGT-A is a screening test, not a guarantee of pregnancy or a healthy baby.

The American Society for Reproductive Medicine (ASRM) states that routine PGT-A for every IVF patient has not been demonstrated to improve outcomes and cannot currently be recommended as a universal screening test. Recent randomized trials have found similar overall pregnancy outcomes in some groups undergoing frozen embryo transfer with PGT-A compared with conventional embryo selection.

So, who might actually benefit from PGT-A? And how much should patients expect to pay in India?

Let's break it down.

What Is PGT-A?

PGT-A stands for Preimplantation Genetic Testing for Aneuploidy.

During IVF, embryos are created in the laboratory. Usually, embryos that develop to the blastocyst stage can undergo a biopsy in which a small number of cells are removed from the outer layer of the embryo.

The cells are then analyzed, commonly using technologies such as next-generation sequencing (NGS), to look for chromosome-number abnormalities.

A typical human embryo has 23 pairs of chromosomes, or 46 chromosomes in total.

PGT-A attempts to classify embryos broadly as:

• Euploid: expected chromosome number
• Aneuploid: an extra or missing chromosome is detected
• Mosaic: the biopsy shows a mixture of chromosome patterns
• No result/inconclusive: the test does not provide a usable result

The embryo itself is generally frozen while the laboratory performs the analysis, with transfer taking place later if an embryo is considered suitable.

PGT-A vs PGT-M vs PGT-SR

One common source of confusion is assuming that all embryo genetic testing is the same.

It is not.

For example, PGT-A is not designed to detect every genetic disease. If a couple has a known inherited mutation, PGT-M may be the relevant test instead.

Therefore, patients should ask their IVF specialist exactly which type of PGT is being recommended and why.

PGT-A Testing Cost in India

The PGT-A testing cost in India varies considerably between clinics and genetic laboratories.

Published 2026 prices show several different pricing models. Some laboratories charge per embryo, while others offer packages covering multiple embryos. Published figures range from roughly ₹30,000 to ₹1,50,000 or more as an additional PGT-A cost, depending on the number of embryos, biopsy, genetic analysis, laboratory and package structure. Some providers publish per-embryo prices around ₹17,000 to ₹30,000, while other packages are priced by batch.

Indicative PGT-A cost in India

These are indicative published prices, not a standard India-wide tariff. For example, Lupin Diagnostics currently lists PGT-A testing starting at ₹12,500 for one embryo and ₹70,000 for up to seven embryos. Other fertility providers publish substantially different ranges depending on whether biopsy and genetic analysis are bundled.

What can increase the cost?

Your final bill may depend on:

• Number of embryos tested
• Embryo biopsy charges
• NGS laboratory charges
• Number of embryos included in a package
• Embryo freezing and storage
• IVF clinic fees
• Genetic counselling
• Whether repeat testing is required
• City and laboratory used

Before starting treatment, ask the clinic for a written PGT-A cost breakdown rather than accepting a single package price.

Is PGT-A Included in IVF Cost?

Usually, PGT-A is an additional expense rather than part of the basic IVF cycle.

A typical IVF bill may include:

1. Ovarian stimulation
2. Monitoring
3. Egg retrieval
4. Fertilization
5. Embryo culture
6. Embryo freezing
7. Embryo transfer

PGT-A introduces additional laboratory and biopsy costs.

This is important when comparing IVF clinics in India because two clinics may advertise similar IVF prices while having very different PGT-A charges.

How Accurate Is PGT-A?

PGT-A accuracy is one of the most misunderstood parts of the process.

PGT-A can provide useful information about chromosome copy number, particularly when modern laboratory methods such as NGS are used. However, the test is not 100% accurate and cannot guarantee that an embryo will implant, result in a healthy pregnancy, or produce a healthy baby.

ASRM highlights an important biological limitation: the laboratory usually tests cells taken from the embryo's trophectoderm, not every cell that will eventually make up the developing pregnancy. Therefore, the biopsy sample may not perfectly represent the entire embryo.

Why can PGT-A produce an uncertain result?

Embryos can contain different cell populations.

This phenomenon is called mosaicism.

For example, the cells sampled during biopsy might contain a mixture of chromosome patterns. The result may therefore be reported as mosaic or intermediate rather than clearly euploid or aneuploid.

ASRM notes that intermediate results can also be influenced by factors such as amplification bias, statistical variation, contamination, biopsy technique and laboratory conditions.

This is why a mosaic result should not automatically be interpreted as meaning that an embryo can never produce a healthy pregnancy.

Does a Euploid PGT-A Result Guarantee a Healthy Baby?

No.

A euploid PGT-A result is reassuring regarding the chromosome-number abnormalities assessed by the test, but it does not mean that the embryo is guaranteed to implant or that the resulting baby will have no medical or genetic condition.

PGT-A does not screen for every:

• Single-gene disorder
• Structural birth defect
• Developmental condition
• Pregnancy complication
• Genetic change outside the scope of the test

Even after transferring a PGT-A-tested embryo, appropriate prenatal screening and diagnostic testing should be discussed with the obstetric team.

Who Actually Needs PGT-A?

This is where the conversation becomes more interesting.

Not everyone undergoing IVF needs PGT-A.

ASRM's 2024 committee opinion concludes that the routine use of PGT-A in all IVF patients has not been demonstrated to improve outcomes.

However, there are situations where discussing PGT-A with a fertility specialist may make sense.

1. Advanced maternal age

The proportion of embryos with chromosomal abnormalities tends to increase with maternal age.

PGT-A may therefore be discussed more frequently in older patients, particularly when the patient has several blastocysts available for testing.

However, age alone does not automatically mean that PGT-A will improve cumulative live birth.

2. Recurrent pregnancy loss

Patients who have experienced repeated miscarriages may discuss PGT-A as part of a broader evaluation.

Chromosomal abnormalities are an important cause of miscarriage, but recurrent pregnancy loss can have many causes.

PGT-A should therefore not be treated as a universal solution for recurrent miscarriage.

3. Repeated IVF implantation failure

Patients with repeated unsuccessful embryo transfers may be offered PGT-A.

The reasoning is straightforward: if chromosomal abnormalities are contributing to unsuccessful implantation, selecting embryos based on PGT-A results might help some patients.

However, the evidence remains mixed, and other causes of implantation failure should also be evaluated.

4. Patients with several blastocysts

PGT-A may be more practically useful when multiple blastocysts are available.

Testing several embryos can potentially identify one or more embryos classified as euploid, allowing the clinical team to prioritize transfers.

But there is an important catch.

If a patient produces only one or two embryos, testing may result in no embryo being available for transfer after the results are obtained.

5. Individualized cases

Some patients may have specific reproductive histories that lead their fertility specialist to recommend genetic testing.

The decision should be based on the patient's age, ovarian reserve, number and quality of embryos, previous IVF outcomes, miscarriage history and genetic background.

Who May Not Need PGT-A?

For a young patient with a good prognosis, no recurrent pregnancy loss, no repeated implantation failure and a reasonable number of good-quality embryos, the benefit of routine PGT-A may be less clear.

ASRM specifically notes that recent randomized trials have not demonstrated a universal improvement in pregnancy outcomes with PGT-A.

This does not mean PGT-A is useless.

It means that PGT-A should be used selectively rather than automatically added to every IVF cycle.

Does PGT-A Improve IVF Success Rates?

This is another area where marketing claims can become misleading.

PGT-A can improve the chance that a particular embryo selected for transfer is classified as euploid. But that does not necessarily mean that testing every embryo increases the overall chance of having a baby from the entire IVF cycle.

ASRM's review of randomized trials found that overall outcomes were similar between PGT-A and conventional embryo selection in important study populations. In the STAR trial, for example, ongoing pregnancy outcomes were not significantly different between the PGT-A and control groups when analyzed per embryo transfer or by intention to treat.

The distinction is important:

Better embryo selection does not automatically equal a higher cumulative live birth rate.

What Happens If All Embryos Are Abnormal?

This is one of the most important questions to ask before paying for PGT-A.

Suppose five embryos are tested and none are classified as euploid.

The patient may then face several possibilities:

• Another IVF cycle
• Reviewing whether an embryo classified as mosaic could be considered
• Considering donor eggs or sperm in appropriate circumstances
• Further genetic counselling
• Re-evaluating the overall fertility strategy

This possibility should be discussed before testing.

The psychological and financial impact of receiving a result with no transferable euploid embryos should not be overlooked.

What Does a Mosaic PGT-A Result Mean?

Mosaicism is one of the most complicated areas of embryo genetic testing in India and worldwide.

A mosaic result generally means that the biopsy showed different chromosome patterns among the sampled cells.

It does not necessarily mean that every cell in the embryo is abnormal.

ASRM notes that mosaic results can be difficult to interpret because the biopsy is only a small sample and intermediate copy-number findings can have multiple possible explanations.

Some mosaic embryos have resulted in healthy pregnancies, but transfer decisions require careful counselling because outcomes can differ depending on the chromosome involved and the nature of the mosaic result.

Patients should ask their clinic:

• How does your laboratory classify mosaic embryos?
• Do you transfer mosaic embryos?
• Which mosaic results are considered higher or lower priority?
• Do you have a genetic counsellor?
• What prenatal testing is recommended after a mosaic embryo transfer?

PGT-A vs Morphology-Based Embryo Selection

Without PGT-A, embryologists primarily assess embryos using characteristics such as:

• Cell development
• Blastocyst expansion
• Inner cell mass appearance
• Trophectoderm appearance
• Developmental timing

PGT-A adds genetic information about chromosome copy number.

Neither approach provides a perfect prediction of reproductive potential.

A beautiful-looking embryo can be aneuploid, while an embryo with less impressive morphology can sometimes result in pregnancy.

This is why PGT-A should be viewed as one piece of information, not an absolute ranking system for embryos.

How PGT-A Works: Step-by-Step

The typical process looks like this:

Step 1: IVF stimulation

The ovaries are stimulated to produce multiple follicles.

Step 2: Egg retrieval

Eggs are collected and fertilized in the laboratory.

Step 3: Embryo development

Embryos are cultured until the blastocyst stage when possible.

Step 4: Embryo biopsy

A small sample of cells is removed from the trophectoderm.

Step 5: Genetic analysis

The biopsy is sent to a specialized laboratory for chromosome analysis.

Step 6: Embryo freezing

Embryos are generally cryopreserved while testing is completed.

Step 7: Results

Embryos may be reported as euploid, aneuploid, mosaic or inconclusive, depending on the laboratory's reporting system.

Step 8: FET

If an embryo is selected for transfer, a frozen embryo transfer cycle can be planned.

Questions to Ask Before Paying for PGT-A

Before adding PGT-A to your IVF treatment, ask your fertility clinic:

1. Why do you recommend PGT-A for my specific case?
2. How many embryos do you expect me to have available for testing?
3. How much does PGT-A cost per embryo?
4. Does the price include biopsy and NGS analysis?
5. Is embryo freezing included?
6. What happens if no embryo is classified as euploid?
7. How are mosaic results reported?
8. Do you transfer mosaic embryos?
9. What is your laboratory's turnaround time?
10. What are your live birth outcomes with and without PGT-A?
11. Are your statistics reported per transfer or per IVF cycle?
12. Will I still need prenatal genetic screening after a euploid embryo transfer?

These questions can turn a vague "PGT-A package" into an actual treatment and financial plan.

Is PGT-A Worth the Cost in India?

There is no universal yes or no answer.

For some patients, the potential benefit of selecting embryos based on chromosome testing may justify the additional expense.

For others, especially patients with a good prognosis and limited numbers of embryos, the evidence may not support routine testing.

The economics also depend on how many embryos are available.

For example, testing five embryos at a per-embryo price can cost substantially more than testing one or two. Published Indian prices vary widely because clinics and laboratories use different package structures.

Therefore, patients should compare the total treatment cost, not just the advertised PGT-A price.

Final Takeaway

PGT-A testing in India can provide valuable information about chromosome number in embryos created through IVF, but it is not a universal requirement and it is not a guarantee of pregnancy or a healthy baby.

The PGT-A testing cost in India can range from tens of thousands of rupees to well over ₹1 lakh depending on the number of embryos tested, biopsy charges, laboratory fees and clinic package. Published 2026 prices demonstrate substantial variation, so obtaining a written quote is essential.

As for PGT-A accuracy, modern testing can provide useful chromosome information, but mosaicism, sampling limitations and laboratory factors mean that results must be interpreted carefully.

Most importantly, PGT-A should not simply be added to an IVF cycle because it sounds like the more advanced option.

The right question is:

"What specific problem are we trying to solve by testing these embryos?"

For patients with advanced maternal age, recurrent pregnancy loss, repeated implantation failure, or particular reproductive/genetic circumstances, PGT-A may be worth discussing. For other patients, conventional embryo selection may remain a reasonable approach.

A fertility specialist and, when appropriate, a genetic counsellor can help determine whether the potential benefits justify the additional cost and limitations in your individual situation.

Medical disclaimer: This article is for educational purposes only and does not replace individualized medical or genetic counselling. IVF and PGT-A outcomes vary by age, ovarian reserve, embryo number and quality, laboratory performance, medical history and other factors. PGT-A cannot guarantee implantation, pregnancy or a healthy baby.